 Corrella Detweiler
Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Salmonella typhimurium | 22 | 2022 | 174 | 6.850 |
Why?
| | Macrophages | 21 | 2020 | 1324 | 4.440 |
Why?
| | Salmonella Infections | 8 | 2022 | 51 | 2.840 |
Why?
| | Anti-Bacterial Agents | 10 | 2022 | 1517 | 2.670 |
Why?
| | Salmonella enterica | 6 | 2020 | 53 | 2.330 |
Why?
| | Salmonella Infections, Animal | 8 | 2019 | 38 | 2.270 |
Why?
| | Phagocytosis | 5 | 2015 | 364 | 1.840 |
Why?
| | Gram-Negative Bacteria | 3 | 2022 | 70 | 1.790 |
Why?
| | Microbiology | 10 | 2020 | 19 | 1.760 |
Why?
| | Bacterial Proteins | 11 | 2016 | 759 | 1.620 |
Why?
| | Iron | 3 | 2017 | 248 | 1.410 |
Why?
| | Periodicals as Topic | 11 | 2020 | 191 | 1.370 |
Why?
| | Membrane Transport Proteins | 4 | 2018 | 137 | 1.310 |
Why?
| | Cation Transport Proteins | 4 | 2016 | 99 | 1.100 |
Why?
| | Virulence Factors | 4 | 2016 | 140 | 1.090 |
Why?
| | Bacterial Outer Membrane Proteins | 2 | 2022 | 58 | 1.040 |
Why?
| | Microbial Sensitivity Tests | 4 | 2021 | 302 | 1.040 |
Why?
| | Immunity, Innate | 2 | 2020 | 745 | 0.990 |
Why?
| | Mice | 24 | 2022 | 15528 | 0.920 |
Why?
| | Host-Pathogen Interactions | 3 | 2020 | 300 | 0.920 |
Why?
| | Cell Membrane | 3 | 2022 | 710 | 0.900 |
Why?
| | Gene Expression Regulation, Bacterial | 6 | 2015 | 279 | 0.900 |
Why?
| | Cardiolipins | 1 | 2022 | 73 | 0.840 |
Why?
| | Typhoid Fever | 2 | 2012 | 10 | 0.810 |
Why?
| | Capecitabine | 1 | 2021 | 46 | 0.800 |
Why?
| | Staphylococcus | 1 | 2021 | 68 | 0.800 |
Why?
| | Animals | 30 | 2022 | 33399 | 0.800 |
Why?
| | Societies, Scientific | 5 | 2020 | 49 | 0.790 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2020 | 39 | 0.760 |
Why?
| | Fluorouracil | 1 | 2021 | 151 | 0.760 |
Why?
| | Drug Resistance, Multiple, Bacterial | 4 | 2021 | 63 | 0.750 |
Why?
| | Staphylococcal Infections | 2 | 2021 | 346 | 0.740 |
Why?
| | Clofazimine | 1 | 2020 | 14 | 0.740 |
Why?
| | Siderophores | 2 | 2017 | 9 | 0.720 |
Why?
| | Erythrocytes | 2 | 2015 | 641 | 0.720 |
Why?
| | Biofilms | 2 | 2021 | 231 | 0.700 |
Why?
| | Racism | 5 | 2020 | 102 | 0.690 |
Why?
| | Salmonella | 3 | 2017 | 54 | 0.670 |
Why?
| | Metabolic Networks and Pathways | 1 | 2019 | 176 | 0.660 |
Why?
| | Dipeptides | 1 | 2018 | 51 | 0.640 |
Why?
| | Bacterial Load | 1 | 2018 | 61 | 0.640 |
Why?
| | Small Molecule Libraries | 1 | 2018 | 80 | 0.620 |
Why?
| | Disease Models, Animal | 6 | 2013 | 3730 | 0.610 |
Why?
| | High-Throughput Screening Assays | 1 | 2018 | 122 | 0.580 |
Why?
| | Lipid Metabolism | 1 | 2019 | 477 | 0.570 |
Why?
| | Antimicrobial Cationic Peptides | 2 | 2009 | 78 | 0.560 |
Why?
| | Escherichia coli Proteins | 2 | 2015 | 170 | 0.550 |
Why?
| | Drug Tolerance | 1 | 2015 | 78 | 0.530 |
Why?
| | Bacterial Toxins | 1 | 2015 | 106 | 0.520 |
Why?
| | Cells | 1 | 2015 | 24 | 0.510 |
Why?
| | Oxides | 1 | 2015 | 42 | 0.500 |
Why?
| | Antibodies | 1 | 2017 | 392 | 0.500 |
Why?
| | Spleen | 5 | 2015 | 510 | 0.480 |
Why?
| | Metal Nanoparticles | 1 | 2015 | 73 | 0.480 |
Why?
| | Enterobactin | 1 | 2013 | 6 | 0.470 |
Why?
| | Anemia | 1 | 2015 | 146 | 0.470 |
Why?
| | Leukocytes | 1 | 2014 | 290 | 0.460 |
Why?
| | Toll-Like Receptor 4 | 1 | 2015 | 330 | 0.440 |
Why?
| | Drug Resistance, Bacterial | 3 | 2017 | 155 | 0.420 |
Why?
| | Trehalose | 1 | 2012 | 35 | 0.420 |
Why?
| | Betaine | 1 | 2012 | 64 | 0.410 |
Why?
| | Salmonella typhi | 3 | 2010 | 12 | 0.410 |
Why?
| | Adaptive Immunity | 1 | 2013 | 161 | 0.410 |
Why?
| | Escherichia coli | 4 | 2022 | 758 | 0.380 |
Why?
| | Mammals | 2 | 2022 | 253 | 0.380 |
Why?
| | Porins | 2 | 2009 | 12 | 0.370 |
Why?
| | Lymphohistiocytosis, Hemophagocytic | 1 | 2010 | 28 | 0.360 |
Why?
| | Periplasm | 1 | 2009 | 10 | 0.360 |
Why?
| | Biological Transport | 2 | 2022 | 382 | 0.350 |
Why?
| | Genes, Bacterial | 2 | 2010 | 162 | 0.350 |
Why?
| | Transcription Factors | 4 | 2006 | 1570 | 0.330 |
Why?
| | Lipopolysaccharides | 3 | 2022 | 870 | 0.330 |
Why?
| | Stress, Physiological | 1 | 2012 | 415 | 0.330 |
Why?
| | Cells, Cultured | 5 | 2020 | 4081 | 0.300 |
Why?
| | Macrophage Activation | 1 | 2008 | 168 | 0.300 |
Why?
| | Liver | 5 | 2014 | 1816 | 0.300 |
Why?
| | Microbial Viability | 3 | 2019 | 81 | 0.300 |
Why?
| | Multienzyme Complexes | 2 | 2006 | 64 | 0.300 |
Why?
| | Phosphoprotein Phosphatases | 2 | 2006 | 67 | 0.300 |
Why?
| | Protein Kinases | 3 | 2006 | 310 | 0.290 |
Why?
| | Interferon-gamma | 3 | 2015 | 737 | 0.260 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2003 | 770 | 0.260 |
Why?
| | Cell Line | 4 | 2015 | 2707 | 0.260 |
Why?
| | Trans-Activators | 2 | 2005 | 373 | 0.260 |
Why?
| | Multigene Family | 1 | 2005 | 200 | 0.250 |
Why?
| | Monocytes | 2 | 2018 | 513 | 0.250 |
Why?
| | Inflammation | 2 | 2012 | 2571 | 0.240 |
Why?
| | Bacteria | 2 | 2022 | 757 | 0.230 |
Why?
| | Mice, Inbred Strains | 3 | 2010 | 405 | 0.230 |
Why?
| | Virulence | 2 | 2014 | 240 | 0.220 |
Why?
| | Glycerophospholipids | 1 | 2022 | 29 | 0.220 |
Why?
| | Phagosomes | 1 | 2022 | 43 | 0.220 |
Why?
| | Amines | 1 | 2022 | 41 | 0.220 |
Why?
| | Mice, Inbred BALB C | 2 | 2021 | 1206 | 0.210 |
Why?
| | Gram-Positive Bacteria | 1 | 2021 | 47 | 0.200 |
Why?
| | Liposomes | 1 | 2022 | 151 | 0.200 |
Why?
| | Administration, Oral | 2 | 2021 | 756 | 0.200 |
Why?
| | Prodrugs | 1 | 2021 | 44 | 0.200 |
Why?
| | Gene Deletion | 2 | 2013 | 361 | 0.200 |
Why?
| | Membrane Lipids | 1 | 2020 | 88 | 0.180 |
Why?
| | DNA-Binding Proteins | 2 | 2005 | 1346 | 0.180 |
Why?
| | RAW 264.7 Cells | 1 | 2020 | 42 | 0.180 |
Why?
| | Mice, Inbred C57BL | 4 | 2020 | 4914 | 0.180 |
Why?
| | Cell Death | 1 | 2001 | 339 | 0.180 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2021 | 190 | 0.170 |
Why?
| | Flow Cytometry | 2 | 2013 | 1085 | 0.170 |
Why?
| | Drug Discovery | 1 | 2020 | 124 | 0.170 |
Why?
| | Humans | 24 | 2022 | 119032 | 0.170 |
Why?
| | Polymyxin B | 2 | 2009 | 22 | 0.160 |
Why?
| | Staphylococcus aureus | 1 | 2021 | 394 | 0.160 |
Why?
| | Cholera Toxin | 1 | 2017 | 28 | 0.150 |
Why?
| | Cell Separation | 1 | 2018 | 296 | 0.150 |
Why?
| | Microscopy | 1 | 2018 | 125 | 0.150 |
Why?
| | Superoxides | 1 | 2017 | 221 | 0.150 |
Why?
| | Research | 1 | 2020 | 411 | 0.150 |
Why?
| | Vacuoles | 1 | 2016 | 33 | 0.140 |
Why?
| | Mutation | 4 | 2014 | 3457 | 0.140 |
Why?
| | Amino Acids | 1 | 2019 | 465 | 0.140 |
Why?
| | Mycobacterium marinum | 1 | 2015 | 2 | 0.140 |
Why?
| | Teichoic Acids | 1 | 2015 | 12 | 0.140 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 356 | 0.140 |
Why?
| | Toll-Like Receptor 9 | 1 | 2015 | 30 | 0.130 |
Why?
| | Meningitis | 1 | 2016 | 74 | 0.130 |
Why?
| | 3T3 Cells | 1 | 2015 | 141 | 0.130 |
Why?
| | Adjuvants, Immunologic | 1 | 2017 | 207 | 0.130 |
Why?
| | Mice, Inbred C3H | 1 | 2015 | 250 | 0.130 |
Why?
| | Bacillus subtilis | 1 | 2015 | 61 | 0.130 |
Why?
| | Duodenum | 1 | 2015 | 67 | 0.130 |
Why?
| | Toll-Like Receptor 2 | 1 | 2015 | 127 | 0.130 |
Why?
| | Gastrointestinal Tract | 1 | 2017 | 175 | 0.130 |
Why?
| | Female | 8 | 2021 | 61588 | 0.120 |
Why?
| | Glucose | 1 | 2019 | 954 | 0.120 |
Why?
| | Immunization | 1 | 2017 | 412 | 0.120 |
Why?
| | Species Specificity | 2 | 2013 | 565 | 0.120 |
Why?
| | Base Sequence | 3 | 2006 | 2160 | 0.110 |
Why?
| | Yersinia pseudotuberculosis Infections | 1 | 2012 | 1 | 0.110 |
Why?
| | Yersinia pseudotuberculosis | 1 | 2012 | 3 | 0.110 |
Why?
| | Cell Movement | 1 | 2016 | 897 | 0.110 |
Why?
| | Salinity | 1 | 2012 | 19 | 0.110 |
Why?
| | Salts | 1 | 2012 | 39 | 0.110 |
Why?
| | Molecular Sequence Data | 3 | 2006 | 2873 | 0.100 |
Why?
| | RNA, Messenger | 2 | 2015 | 2661 | 0.100 |
Why?
| | Chemokines | 1 | 2013 | 230 | 0.100 |
Why?
| | NF-kappa B | 1 | 2015 | 670 | 0.100 |
Why?
| | Immunophenotyping | 1 | 2012 | 278 | 0.100 |
Why?
| | Mutation, Missense | 1 | 2013 | 300 | 0.100 |
Why?
| | Genomic Islands | 1 | 2010 | 8 | 0.090 |
Why?
| | Cytoplasmic Vesicles | 1 | 2010 | 12 | 0.090 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 536 | 0.090 |
Why?
| | Epithelial Cells | 1 | 2016 | 963 | 0.090 |
Why?
| | Mice, Knockout | 2 | 2015 | 2680 | 0.090 |
Why?
| | Hydrogen Peroxide | 1 | 2012 | 305 | 0.090 |
Why?
| | Splenomegaly | 1 | 2010 | 17 | 0.090 |
Why?
| | Bone Marrow Diseases | 1 | 2010 | 18 | 0.090 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 140 | 0.090 |
Why?
| | Gastrointestinal Microbiome | 1 | 2017 | 548 | 0.090 |
Why?
| | Ferritins | 1 | 2010 | 61 | 0.090 |
Why?
| | Cathelicidins | 1 | 2009 | 39 | 0.090 |
Why?
| | Editorial Policies | 2 | 2020 | 46 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2013 | 1295 | 0.090 |
Why?
| | Chromatography, Affinity | 1 | 2009 | 86 | 0.090 |
Why?
| | Dendritic Cells | 1 | 2013 | 442 | 0.090 |
Why?
| | Immunoprecipitation | 1 | 2009 | 161 | 0.090 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 146 | 0.090 |
Why?
| | Immunoblotting | 1 | 2009 | 307 | 0.080 |
Why?
| | Apoptosis | 2 | 2012 | 2484 | 0.080 |
Why?
| | Fever | 1 | 2010 | 283 | 0.080 |
Why?
| | Thrombocytopenia | 1 | 2010 | 185 | 0.080 |
Why?
| | Carrier State | 1 | 2008 | 57 | 0.080 |
Why?
| | Jurkat Cells | 1 | 2007 | 134 | 0.080 |
Why?
| | Gene Expression Profiling | 2 | 2005 | 1597 | 0.080 |
Why?
| | Gammaproteobacteria | 1 | 2007 | 14 | 0.070 |
Why?
| | Phosphotransferases | 1 | 2006 | 27 | 0.070 |
Why?
| | Sigma Factor | 1 | 2006 | 33 | 0.070 |
Why?
| | Bone Marrow Cells | 1 | 2007 | 273 | 0.070 |
Why?
| | Adenosine Monophosphate | 1 | 2006 | 51 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2009 | 1012 | 0.070 |
Why?
| | Phylogeny | 2 | 2007 | 817 | 0.070 |
Why?
| | Cytokines | 1 | 2013 | 1900 | 0.060 |
Why?
| | Amino Acid Motifs | 1 | 2005 | 200 | 0.060 |
Why?
| | Nitric Oxide | 1 | 2010 | 893 | 0.060 |
Why?
| | Healthcare Disparities | 2 | 2020 | 496 | 0.060 |
Why?
| | Sequence Alignment | 1 | 2005 | 336 | 0.060 |
Why?
| | Biomedical Research | 2 | 2020 | 612 | 0.060 |
Why?
| | Molecular Chaperones | 1 | 2005 | 174 | 0.060 |
Why?
| | United States | 4 | 2020 | 12557 | 0.060 |
Why?
| | Chronic Disease | 1 | 2010 | 1637 | 0.060 |
Why?
| | Protein Binding | 1 | 2009 | 1975 | 0.060 |
Why?
| | Time Factors | 2 | 2012 | 6414 | 0.060 |
Why?
| | Bacterial Capsules | 1 | 2003 | 32 | 0.060 |
Why?
| | Promoter Regions, Genetic | 2 | 2005 | 1158 | 0.060 |
Why?
| | Down-Regulation | 1 | 2005 | 627 | 0.050 |
Why?
| | Computational Biology | 1 | 2007 | 588 | 0.050 |
Why?
| | Genome, Bacterial | 1 | 2003 | 109 | 0.050 |
Why?
| | Genes, cdc | 1 | 2001 | 10 | 0.050 |
Why?
| | Blotting, Northern | 1 | 2001 | 194 | 0.050 |
Why?
| | Caspase 1 | 1 | 2001 | 143 | 0.050 |
Why?
| | Male | 3 | 2020 | 57818 | 0.050 |
Why?
| | Laboratory Personnel | 1 | 2020 | 3 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2001 | 268 | 0.050 |
Why?
| | Bias | 1 | 2020 | 198 | 0.040 |
Why?
| | RNA, Bacterial | 1 | 2000 | 175 | 0.040 |
Why?
| | Publishing | 1 | 2020 | 131 | 0.040 |
Why?
| | Survival Rate | 1 | 2003 | 1720 | 0.040 |
Why?
| | Communicable Diseases | 1 | 2020 | 132 | 0.040 |
Why?
| | Health Status Disparities | 1 | 2020 | 209 | 0.040 |
Why?
| | DNA, Fungal | 1 | 1997 | 69 | 0.040 |
Why?
| | Gene Expression Regulation, Fungal | 1 | 1997 | 67 | 0.040 |
Why?
| | Fungal Proteins | 1 | 1997 | 130 | 0.040 |
Why?
| | Ataxia | 1 | 2016 | 38 | 0.040 |
Why?
| | Cerebral Ventricles | 1 | 2016 | 48 | 0.040 |
Why?
| | Colony Count, Microbial | 1 | 2016 | 120 | 0.040 |
Why?
| | Neutrophil Infiltration | 1 | 2016 | 97 | 0.040 |
Why?
| | DNA Replication | 1 | 1997 | 211 | 0.030 |
Why?
| | Optical Imaging | 1 | 2016 | 56 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2001 | 1056 | 0.030 |
Why?
| | Encephalitis | 1 | 2016 | 129 | 0.030 |
Why?
| | Intestines | 1 | 2018 | 332 | 0.030 |
Why?
| | Bacteremia | 1 | 2016 | 161 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2016 | 187 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2017 | 940 | 0.030 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1997 | 348 | 0.030 |
Why?
| | Caenorhabditis elegans | 1 | 2017 | 287 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 1997 | 565 | 0.030 |
Why?
| | Nanoparticles | 1 | 2017 | 325 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 1 | 1997 | 495 | 0.030 |
Why?
| | Carrier Proteins | 1 | 1997 | 726 | 0.030 |
Why?
| | Signal Transduction | 1 | 2006 | 4713 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 1997 | 597 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2016 | 1691 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 710 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2018 | 1753 | 0.020 |
Why?
| | Shigella flexneri | 1 | 2007 | 11 | 0.020 |
Why?
| | Databases, Protein | 1 | 2007 | 60 | 0.020 |
Why?
| | Likelihood Functions | 1 | 2007 | 136 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2007 | 104 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2007 | 481 | 0.020 |
Why?
| | Brain | 1 | 2016 | 2490 | 0.020 |
Why?
| | Models, Genetic | 1 | 2007 | 595 | 0.010 |
Why?
| | Serotyping | 1 | 2003 | 32 | 0.010 |
Why?
| | Models, Statistical | 1 | 2007 | 636 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 2003 | 193 | 0.010 |
Why?
| | U937 Cells | 1 | 2001 | 26 | 0.010 |
Why?
| | Interleukin-18 | 1 | 2001 | 229 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2001 | 828 | 0.010 |
Why?
| | Spectrometry, Fluorescence | 1 | 2000 | 173 | 0.010 |
Why?
| | Algorithms | 1 | 2007 | 1543 | 0.010 |
Why?
| | Models, Biological | 1 | 2007 | 1715 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 2000 | 314 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2003 | 1795 | 0.010 |
Why?
| | Interleukin-1 | 1 | 2001 | 980 | 0.010 |
Why?
| | Cell Cycle | 1 | 1997 | 550 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2000 | 1323 | 0.010 |
Why?
|
|
Detweiler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|